Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms

Mikaela D. Stewart, Emily D. Duncan, Ernesto Coronado, Paul A. DaRosa, Jonathan Pruneda, Peter S. Brzovic, Rachel E. Klevit

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The tumor-suppressor protein BRCA1 works with BARD1 to catalyze the transfer of ubiquitin onto protein substrates. The N-terminal regions of BRCA1 and BARD1 that contain their RING domains are responsible for dimerization and ubiquitin ligase activity. This activity is a common feature among hundreds of human RING domain-containing proteins. RING domains bind and activate E2 ubiquitin-conjugating enzymes to promote ubiquitin transfer to substrates. We show that the identity of residues at specific positions in the RING domain can tune activity levels up or down. We report substitutions that create a structurally intact BRCA1/BARD1 heterodimer that is inactive in vitro with all E2 enzymes. Other substitutions in BRCA1 or BARD1 RING domains result in hyperactivity, revealing that both proteins have evolved attenuated activity. Loss of attenuation results in decreased product specificity, providing a rationale for why nature has tuned BRCA1 activity. The ability to tune BRCA1 provides powerful tools for understanding its biological functions and provides a basis to assess mechanisms for rescuing the activity of cancer-associated variations. Beyond the applicability to BRCA1, we show the identity of residues at tuning positions that can be used to predict and modulate the activity of an unrelated RING E3 ligase. These findings provide valuable insights into understanding the mechanism and function of RING E3 ligases like BRCA1.

Original languageEnglish (US)
Pages (from-to)475-483
Number of pages9
JournalProtein Science
Volume26
Issue number3
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

Fingerprint

Ligases
Ubiquitin
Ubiquitin-Protein Ligases
Tuning
Substitution reactions
Ubiquitin-Conjugating Enzymes
Tumor Suppressor Proteins
Proteins
Dimerization
Substrates
Enzymes
Neoplasms

Keywords

  • BARD1
  • BRCA1
  • RING domain
  • ubiquitin
  • ubiquitin E3 ligase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Stewart, M. D., Duncan, E. D., Coronado, E., DaRosa, P. A., Pruneda, J., Brzovic, P. S., & Klevit, R. E. (2017). Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms. Protein Science, 26(3), 475-483. https://doi.org/10.1002/pro.3091

Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms. / Stewart, Mikaela D.; Duncan, Emily D.; Coronado, Ernesto; DaRosa, Paul A.; Pruneda, Jonathan; Brzovic, Peter S.; Klevit, Rachel E.

In: Protein Science, Vol. 26, No. 3, 01.03.2017, p. 475-483.

Research output: Contribution to journalArticle

Stewart, MD, Duncan, ED, Coronado, E, DaRosa, PA, Pruneda, J, Brzovic, PS & Klevit, RE 2017, 'Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms', Protein Science, vol. 26, no. 3, pp. 475-483. https://doi.org/10.1002/pro.3091
Stewart MD, Duncan ED, Coronado E, DaRosa PA, Pruneda J, Brzovic PS et al. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms. Protein Science. 2017 Mar 1;26(3):475-483. https://doi.org/10.1002/pro.3091
Stewart, Mikaela D. ; Duncan, Emily D. ; Coronado, Ernesto ; DaRosa, Paul A. ; Pruneda, Jonathan ; Brzovic, Peter S. ; Klevit, Rachel E. / Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms. In: Protein Science. 2017 ; Vol. 26, No. 3. pp. 475-483.
@article{189215eeaff44f988f3aa0e1ebeb8ce4,
title = "Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms",
abstract = "The tumor-suppressor protein BRCA1 works with BARD1 to catalyze the transfer of ubiquitin onto protein substrates. The N-terminal regions of BRCA1 and BARD1 that contain their RING domains are responsible for dimerization and ubiquitin ligase activity. This activity is a common feature among hundreds of human RING domain-containing proteins. RING domains bind and activate E2 ubiquitin-conjugating enzymes to promote ubiquitin transfer to substrates. We show that the identity of residues at specific positions in the RING domain can tune activity levels up or down. We report substitutions that create a structurally intact BRCA1/BARD1 heterodimer that is inactive in vitro with all E2 enzymes. Other substitutions in BRCA1 or BARD1 RING domains result in hyperactivity, revealing that both proteins have evolved attenuated activity. Loss of attenuation results in decreased product specificity, providing a rationale for why nature has tuned BRCA1 activity. The ability to tune BRCA1 provides powerful tools for understanding its biological functions and provides a basis to assess mechanisms for rescuing the activity of cancer-associated variations. Beyond the applicability to BRCA1, we show the identity of residues at tuning positions that can be used to predict and modulate the activity of an unrelated RING E3 ligase. These findings provide valuable insights into understanding the mechanism and function of RING E3 ligases like BRCA1.",
keywords = "BARD1, BRCA1, RING domain, ubiquitin, ubiquitin E3 ligase",
author = "Stewart, {Mikaela D.} and Duncan, {Emily D.} and Ernesto Coronado and DaRosa, {Paul A.} and Jonathan Pruneda and Brzovic, {Peter S.} and Klevit, {Rachel E.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/pro.3091",
language = "English (US)",
volume = "26",
pages = "475--483",
journal = "Protein Science",
issn = "0961-8368",
publisher = "Cold Spring Harbor Laboratory Press",
number = "3",

}

TY - JOUR

T1 - Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms

AU - Stewart, Mikaela D.

AU - Duncan, Emily D.

AU - Coronado, Ernesto

AU - DaRosa, Paul A.

AU - Pruneda, Jonathan

AU - Brzovic, Peter S.

AU - Klevit, Rachel E.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The tumor-suppressor protein BRCA1 works with BARD1 to catalyze the transfer of ubiquitin onto protein substrates. The N-terminal regions of BRCA1 and BARD1 that contain their RING domains are responsible for dimerization and ubiquitin ligase activity. This activity is a common feature among hundreds of human RING domain-containing proteins. RING domains bind and activate E2 ubiquitin-conjugating enzymes to promote ubiquitin transfer to substrates. We show that the identity of residues at specific positions in the RING domain can tune activity levels up or down. We report substitutions that create a structurally intact BRCA1/BARD1 heterodimer that is inactive in vitro with all E2 enzymes. Other substitutions in BRCA1 or BARD1 RING domains result in hyperactivity, revealing that both proteins have evolved attenuated activity. Loss of attenuation results in decreased product specificity, providing a rationale for why nature has tuned BRCA1 activity. The ability to tune BRCA1 provides powerful tools for understanding its biological functions and provides a basis to assess mechanisms for rescuing the activity of cancer-associated variations. Beyond the applicability to BRCA1, we show the identity of residues at tuning positions that can be used to predict and modulate the activity of an unrelated RING E3 ligase. These findings provide valuable insights into understanding the mechanism and function of RING E3 ligases like BRCA1.

AB - The tumor-suppressor protein BRCA1 works with BARD1 to catalyze the transfer of ubiquitin onto protein substrates. The N-terminal regions of BRCA1 and BARD1 that contain their RING domains are responsible for dimerization and ubiquitin ligase activity. This activity is a common feature among hundreds of human RING domain-containing proteins. RING domains bind and activate E2 ubiquitin-conjugating enzymes to promote ubiquitin transfer to substrates. We show that the identity of residues at specific positions in the RING domain can tune activity levels up or down. We report substitutions that create a structurally intact BRCA1/BARD1 heterodimer that is inactive in vitro with all E2 enzymes. Other substitutions in BRCA1 or BARD1 RING domains result in hyperactivity, revealing that both proteins have evolved attenuated activity. Loss of attenuation results in decreased product specificity, providing a rationale for why nature has tuned BRCA1 activity. The ability to tune BRCA1 provides powerful tools for understanding its biological functions and provides a basis to assess mechanisms for rescuing the activity of cancer-associated variations. Beyond the applicability to BRCA1, we show the identity of residues at tuning positions that can be used to predict and modulate the activity of an unrelated RING E3 ligase. These findings provide valuable insights into understanding the mechanism and function of RING E3 ligases like BRCA1.

KW - BARD1

KW - BRCA1

KW - RING domain

KW - ubiquitin

KW - ubiquitin E3 ligase

UR - http://www.scopus.com/inward/record.url?scp=85010905723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010905723&partnerID=8YFLogxK

U2 - 10.1002/pro.3091

DO - 10.1002/pro.3091

M3 - Article

VL - 26

SP - 475

EP - 483

JO - Protein Science

JF - Protein Science

SN - 0961-8368

IS - 3

ER -